Date: 2008-07-01
Name(s): Sahoo, Alison
Description: The rising prevalence of obesity is a growing problem in developed countries, with 32% of Americans and 17% of EU residents considered obese in 2008. With co-morbidities costing health services many billions this represents a key area of opportunity.
Date: 2009-05-22
Name(s): Sahoo, Alison
Description: In both the US and EU, the clinical nutrition industry is undergoing a significant shift as major players re-align their businesses. Rising demand, coupled with the introduction of new clinical nutrition products is driving market growth.
Date: 2011-07-29
Name(s): Barton, Cheryl L., Sleigh, Sara
Description: Medical nutrition is an emerging concept based on scientific research into the relationship between nutrition and disease. Leading companies are now developing products that aim to meet the nutritional requirements of specific diseases.
Date: 2009-07-27
Name(s): Tallon, Mark J.
Description: Recent data suggests the global sports nutrition market is currently valued at between $27-32bn. 'Sports nutrition' implies use only by individuals involved in sports. However it now describes a diverse audience from teenagers to professionals.
Date: 2010-03-29
Name(s): Cavanagh, Joan
Description: The flurry of recent industry acquisitions and alliances focused on product portfolios and distribution networks in the emerging markets underscores the attractiveness of these areas for the pharmaceutical industry.
Date: 2011-03-21
Name(s): Barton, Cheryl L.
Description: Malnutrition affects more than 925 million people globally. In developing economies initiatives address micronutrient malnutrition through supplementation and food fortification, whilst in developed countries it is underdiagnosed and undertreated.
Date: 2010-06-08
Description: Market opportunities for injectable bio-implants are high in an increasingly aging population that demands fast, effective, and safe treatments for age-related conditions.
Date: 2008-05-12
Name(s): Humphries, Gavin
Description: With increasing consumer interest in both health and nutrition, food and drinks that are medicinal in some way are well placed to benefit from this trend. Daily dose products help to boost consumption frequency and brand loyalty.
Date: 2009-09-02
Name(s): Berezai, Piers
Description: This report breaks new ground and is the first market analysis to identify and size what is set to be a growth area and the first to establish what the crucial steps to developing successful marketing strategies in this area will be.
Date: 2010-01-04
Name(s): Thornton, Peter
Description: Orphan drugs present opportunities to pharma companies looking to move into niche indications with high unmet needs. Although many successful, profitable orphan drugs (Gleevec, NovoSeven) orphan drug development must be approached carefully.
Date: 2009-10-28
Name(s): Berezai, Piers
Description: Advances in technology and investments in research and development have combined with a greater understanding of the potential health benefits of Whey Products. Ingredients suppliers and product manufacturers alike seeking to target this growth area.
Date: 2011-05-31
Name(s): Green, G. C.
Description: Amidst pressing needs to accelerate drug development while controlling costs, pharma companies and CROs are using new information technologies to improve clinical trials. This report examines these technologies and how they can be best applied.
Date: 2007-11-16
Name(s): Sahoo, Alison
Description: Partnerships with contract organizations can help to develop closer relationships between sponsors and contractors, facilitating a mutual understanding of organizational structure, culture and priority that can lead to improved project outcomes.
Date: 2010-01-29
Name(s): Doxey, Mark
Description: Developed OTC markets are heavily reliant on Rx-to-OTC switching of new generation products to drive growth. The Power of Switch was brought into focus in 2009 with the first ever use of the Central Procedure for switching throughout the EU.
